Background and Purpose: Alzheimer's disease (AD) leads to cognitive dysfunction and neuronal loss, both of which can be exacerbated by seizures. For the treatment and diagnosis of AD, it is imperative to identify the cortical characteristics of comorbidities of AD such as seizures. The present study investigated the alterations in cortical volumes in patients with comorbid AD and seizures.
Introduction
Alzheimer's disease (AD) is the most common cause of dementia.
Patients with AD present with memory impairment and cognitive dysfunction, and report difficulty in activities of daily living. Cognitive dysfunction in AD can progress more rapidly, 1,2 and occur earlier 3 in patients with comorbid seizures than in those without. The incidence of epilepsy in AD patients is three times greater than in age-matched controls. 4 This result was found not only in the late, 5 but also in the early stage of AD, and in mild cognitive impairment (MCI). 3 In light of the harmful consequences relating to cognitive function and increased risk of epilepsy in AD patients, treatment and diagnosis of AD with comorbid epilepsy is imperative, and the examination of its basic neural properties is essential. The increased risk of epilepsy in AD patients suggests a possible pathological link between epilepsy and AD. A high level of beta-amyloid (Aβ) in the brain can cause aberrant excessive neuronal activity, 6 ,7 which in turn facilitates the synaptic release of Aβ, leading to cell death and cognitive decline in the AD brain. 8 This vicious synergistic effect has been seen in pathological alterations at the cellular-level of the postmortem human, 9 and transgenic mouse brain. 10 In this study, we investigated alterations in cortical volume of AD patients with seizures, compared to those without seizures. As a preliminary study, we compared cortical volumes between six early AD 
Methods

Subjects
We designed a retrospective study by collecting brain magnetic resonance images (MRIs) of patients who visited Dongguk University Ilsan Hospital from January to May of 2017. We included patients who were diagnosed with amnestic MCI or probable AD according to the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria. 11 The inclusion criteria were a diagnosis of probable AD, a global deterioration scale (GDS) of 3 or 4, a score between 10-26 on the Korean version of the mini-mental state examination (MMSE), age over 50 years, and an absence of a history of other psychiatric disorders. Of the patients who satisfied the above criteria, we grouped those patients without clinical seizures as "AD patients without seizures (AD-No Seizure)", and those with clinical seizures as "AD patients with seizures (AD-Seizure)". As it was more difficult to find AD/MCI patients with seizures than those without seizures, we adjusted the number of patients in the AD-No Seizure group to match that of the AD-Seizure group while matching as closely as possible for age and gender. In total, we included 12 patients: six patients in the AD-No Seizure and six patients in the AD-Seizure group. The demographic information and neuropsychological results of the selected patients are summarized in Table 1 . Individual brain structure and activity were examined with MRI, electroencephalography (EEG) recording, and medical examination.
In the AD-No Seizure group, the patients' EEG recordings showed normal electrical brain activity. In the AD-Seizure group, all patients had episodes of dialeptic seizures (i.e., an alteration of consciousness) 12 without generalized tonic-clonic seizures. One patient had a vertiginous aura, and one patient experienced visual aura. Although definite epileptic discharges were observed in only one patient, semi-rhythmic theta activity across frontotemporal areas was observed in all patients in the AD-Seizure group. With anti-epileptic drug treatment, all patients with seizures had no, or reduced, recurrence of dialeptic seizure or amnesic events. Examination of all MRIs revealed that white matter hyperintensity of all patients was minimal.
Brain MRI acquisition
For each participant, a high-resolution T1-weighted 3-dimensional anatomical scan was obtained using 3T Magnetom Skyra MRI scanner (Siemens, Germany) at the Dongguk University Ilsan Hospital, Goyang, Korea. The 3-dimensional magnetization-prepared rapid gradient-echo sequence protocol was used with the following parameters: repetition time = 2,300 ms; echo time = 2.26 ms; field of view = 256 × 256 mm; flip angle = 8°; spatial resolution = 0.5 × 0.5 × 0.5 mm. Two subjects from each group were imaged with slightly different protocols: echo time: 2.98; flip angle = 9°; field of view = 248 × 256 mm; spatial resolution = 1.0 × 1.0 × 1.2 mm.
Gray matter volume calculation
Based on the T1-weighted MRIs of the included patients, gray matter volumes (GMV) were calculated using voxel-based morphometry analysis in the SPM12 toolbox (Wellcome Department of Imaging Neuroscience Group, London, UK) executed in Matlab (MathWorks, Inc., Natick, MA, USA). First, an individual T1-weighted image was segmented, in each participant's native space, into gray matter, white matter, cerebrospinal fluid, skull, soft tissue outside of the brain, and other stuff outside of the head. Then, segmented images were spatially normalized into Montreal Neurological Institute (MNI) space using the DARTEL 13 toolbox in SPM12. The default settings were maintained, and the sample-derived template with a voxel size of 1.5 × 1.5 × 1.5 mm was used. The normalized gray matter images were modulated with the Jacobian determinant maps from the anatomical standardization stage, allowing a quantitative assessment of the regional GMV. Finally, the GMV images were smoothed with an 8 mm full-width-at-half-maximum isotropic Gaussian kernel. As a nuisance variable for the subsequent group analysis, the individual total intracranial volume was calculated as the sum of the gray matter, white matter, and cerebrospinal fluid (CSF) in each subject's native space using SPM12.
Statistical analysis
Group comparisons were performed between the AD-No Seizure and the AD-Seizure group. Age, gender, total intracranial volume, years of education, MMSE, and imaging protocol type were treated as nuisance variables in the general linear model. After applying the gray matter mask based on the sample-derived gray matter template obtained from the DARTEL procedure, the alpha level was set at p < 0.001 with a cluster size ≤ 5 without correction for multiple comparisons. The gray matter mask only included voxels with gray matter intensity ≥ 0.45. While this threshold value was quite strict, it successfully excluded voxels showing white matter hyperintensity from the analysis. For a preliminary study with a small number of observations (i.e., subjects), uncorrected p < 0.001 is quite conservative, so we also applied a more liberal alpha level of uncorrected p < 0.005, to allow observation of cortical volume alterations in more regions. To label the peaks of significant clusters according to Brodmann area (BA), the peak coordinates were converted from MNI space to Talairach space, 14 and anatomical region and BA were identified using Talairach Client.
15,16
Relationship between GMV and cognitive function
To examine the relationship between cortical volume and cognitive function, we estimated correlation coefficients between GMV and MMSE score. The GMV values of each subject were extracted at all peak voxels that showed significant group differences at p < 0.005, and age, gender, total intracranial volume, years of education, and imaging protocol type were regressed out. GMV residuals were used to compute Pearson's correlation coefficients, which were transformed into z-values using Fisher's z transformation, for each group separately, and group differences in correlation coefficients were tested. The absolute values of z-scores were compared between groups using an equation 
Results
GMV alterations in the AD brain with and without comorbid seizures
Group comparisons revealed that the AD-Seizure group showed smaller cortical volume than the AD-No Seizure group in the right inferior parietal lobule, the left lingual gyrus, and cerebellar region (p < 0.001) ( Table 2 ). In addition, at the more liberal threshold of p < 0.005, differences were observed in the left medial frontal (BA 10), angular (BA 39), middle temporal (BA 39) gyri, cerebellar tonsil; the right superior frontal (BA 6), medial frontal (BA 9), inferior frontal (BA 45), parahippocampal (BA 35), lingual (BA 18) gyri and cerebellar tuber (Table 2) .
On the contrary, larger cortical volumes were observed in the AD-Seizure than in the AD-No Seizure group in the left middle frontal (BA 8), postcentral (BA 2), and right middle temporal (BA 39) gyri (p < 0.001) ( Table 2) . At an alpha level of 0.005, the left middle frontal gyrus (BA 6), inferior parietal lobule (BA 40), precuneus (BA 7, 31), cuneus (BA 17, 18) , and middle temporal gyrus (BA 37) also emerged. In the right hemisphere, a cluster consisting of the cingulate (BA 32) and medial frontal (BA 6) gyri; a cluster consisting of the postcentral (BA 3), precentral (BA 4), and superior frontal (BA 6) gyri; and the cerebellar declive were observed (Table 2) .
Relationship between GMV alterations and cognitive function
To examine a relationship between cortical volume alterations and cognitive function, we calculated the correlation coefficient between GMV and MMSE scores separately for each group. We hypothesized that there would be a positive correlation between cortical volume and MMSE score, such that smaller cortical volumes would be associated with cognitive dysfunction in the AD-Seizure group. As expected, in the AD-Seizure group there was a positive association be- Table 2 ). Interestingly, the AD-No Seizure group showed a significant negative correlation between MMSE score and peak volume of the right inferior frontal gyrus (r = -0.86, p = 0.03), and the left cerebellar culmen (r = -0.83, p = 0.04) ( Fig. 1D and E, Table 2 ).
Regions with significantly greater cortical volume in the AD-Seizure group did not show any significant correlation with MMSE score in that group. However, there was a positive correlation between cortical volume and MMSE score in the left middle frontal gyrus (BA 8) in the AD-No Seizure group (Fig. 2, Table 2 ). Comparisons of correlation coefficients between groups were not significantly different based on z-statistics (p > 0.05) ( Table 2) . 
AD-No
Discussion
The present study investigated cortical volumetric and cognitive function alterations related to the comorbidity of AD and seizures.
Comparison of AD patients with seizures and those without seizures revealed seizure-related cortical alterations in the AD brain in the form of either smaller or larger cortical volume in distributed cortical regions. Follow-up correlation analyses revealed that smaller volume of temporal regions in AD patients with seizures was positively associated with cognitive function in the parahippocampal, middle temporal, and angular gyri. These temporal regions, which are well-known for their involvement in encoding and retrieval of information, overlap with regions that exhibited epileptiform activities in the AD-Seizure group. Therefore, our results suggest that smaller volume in temporal brain regions in these patients might indicate a synergistic effect of AD and seizures that alters cortical volume and cognitive function.
By comparing cortical volumes between AD patients with and without seizures, we have revealed cortical alterations in several regions that are specific to AD patients with comorbid seizures. First, we found reduced cortical volume in specific structures in the AD-Seizure group. As the primary difference between groups is the presence of seizures, this may reflect seizure-related cortical volume loss. This result is in line with a previous study using an AD mouse model which suggested that abnormal hyperexcitability of neurons can result in cortical volume loss 8. The cortical volume alterations may also reflect cortical network reorganization via a synergistic effect of seizures and toxic accumulation of Aβ in the AD brain 6, 8. Second, we observed larger cortical volume in different regions in the AD-Seizure group. The present study found both seizure-related cortical volumetric alterations. These findings are in accordance with a rat study reporting that abnormal electrophysiologic activity (i.e., Status Epilepticus and subsequent seizures) can trigger a reorganization of brain morphology by increasing cell size and decreasing dendrite arborization and spine density. 17 To further investigate the relationship between cortical alteration and cognitive function disruption, we performed a correlation analysis. We hypothesized that, in the AD-Seizure group, regions with smaller cortical volume would be related to cognitive dysfunction. As expected, smaller cortical volume of the right parahippocampal, left middle temporal, and angular gyri predicted a low level of cognitive function in these patients. Those regions overlapped with regions shown in this patient group to display abnormal brain activity as assessed by EEG. They are also regions that are known for their contributions to memory function. 18, 19 Specifically, the right parahippocampal gyrus has been reported to be involved in encoding and maintenance of information. 18 Additionally, the peak voxels in the left angular gyrus and middle temporal gyrus fell into BA 39, which has been suggested to play a role in the retrieval of context-dependent semantic information. 19 Taken together, these findings suggest that seizure-related cortical volume loss in temporal regions may contribute to cognitive dysfunction in the AD brain. Although the AD-No Seizure group was included in this study as a control group, and therefore was not of interest in the correlation analysis, we observed an association between cortical volume and cognitive function in this group. Volume of the right inferior frontal gyrus and cerebellum in the AD-No Seizure group was negatively correlated with cognitive function. There is literature that reports no sig-nificant positive correlation between MMSE score and cortical thickness of the right inferior frontal gyrus. 20 However, as this study reported only significantly positive correlation coefficients, we cannot be sure that there were no negative or negligible positive correlations between cortical thickness of this region and cognition. Structural connectivity may, however, provide a possible explanation for the negative correlation seen between cortical volume or thickness and cognitive function. It has been recently reported that diffusion tractography revealed a structural connection between the right inferior frontal gyrus and the pre-supplementary motor area, 21 a region that has been noted to show relatively minimal cortical atrophy in the early stage of AD. 22 Based on these findings, we posit that the relatively preserved cortical volume of pre-supplementary motor regions may serve to preserve a morphometry of the right inferior frontal gyrus, and that this process is anti-correlated with cognitive functional decline. In contrast to several previous studies that have reported a positive correlation between cerebellar volume and MMSE scores in AD patients, 23, 24 we found a negative correlation between the left cerebellar region of the AD-No Seizure group, and cognitive function. Previous studies examined the right hemispheric cerebellum, which have been reported to be related to verbal function. The present study, however, found a negative correlation with the left hemispheric cerebellum, which is typically associated with non-verbal function. 25, 26 This may explain the discrepancies between the previous and present findings. In addition, the AD-No Seizure group also showed a positive correlation between the left middle frontal gyrus (BA 8) and cognitive function. This result is in line with a previous study 20 that reported a significant association between GMV of the caudal part of the middle frontal gyrus and MMSE scores in AD patients. Although the correlation did not reach significance in our study, a marginally strong positive relationship was observed (r = 0.59, p = 0.22).
The present study revealed significant differences in cortical volume between AD-Seizure and AD-No Seizure groups in distributed cortical regions including temporal, frontal, occipital, and cerebellar regions. To our knowledge, this is the first study to present these regional level cortical alterations in patients with AD and comorbid seizures. Pathological alterations in the AD brain in the presence of seizures have been demonstrated mostly at the cellular micro-circuit level of hippocampal formation. 8 Our findings provide a new macro-circuit level perspective of this phenomenon. These macro-scale cortical alterations have been suggested by Noebels 8 in his review article. By examining neuroimaging findings in both AD, and temporal lobe epilepsy, Noebels 8 found that these two disorders showed extensive spatial overlap in volumetric atrophy and hypometabolism in the brain. This suggests that the common features in AD and temporal lobe epilepsy could be reflected in a cortical-level observation.
In this regard, we believe that the present study provides evidence of cortical-level pathological change in the comorbidity of AD and epilepsy.
One of the limitations of the present study is that the mean ages for each group were significantly different (p < 0.005, Table 1 ). As age is a crucial factor affecting cortical volume loss, 27 we controlled for age by including it as a nuisance variable in group analyses. Another limitation of the study is the presence of group differences in cerebrovascular risk factors. Cerebrovascular risk factors such as hypertension and diabetes are known to have an adverse effect on cortical volume and thickness. 28, 29 These risk factors were not controlled across study groups: all the patients of the AD-Seizure group have one or more than one cerebrovascular risk factors such as hypertension, diabetes, and hyperlipidemia, whilst AD-No Seizure group have only one patient with hyperlipidemia. This difference might be related to the age difference between groups in that cerebrovascular risk factors are related to aging. 30 Despite this limitation, both groups did not show much difference in the brain MRI examination: both groups had patients with diffuse brain atrophy and/or cerebral small vessel disease. In addition, angiography did not show any abnormality, hence it does not seem to be possible that vascular factors affect focal brain regions as shown in our findings. To rule out any possible confounding factors for cortical volumes, a future study needs age-matched and cerebrovascular risk factor-controlled/matched groups. In addition, the present study could not include healthy controls in terms of memory function, resulting in an absence of comparisons between patients and healthy controls. Since differences from the healthy controls were unknown for each patient samples in the present study, there was a limit to interpret the results. In a future study, a comparison with healthy controls also needs to be included to derive more convincing results. Lastly, the present study set a liberal alpha level without multiple comparisons corrections to find statistical results. Despite a possibility of increasing false positive rates, we used this liberal alpha level as a pilot study, which needs to observe a trend of cortical alterations in the AD with seizure patients. Besides, with a small number of observations, it was hard to find any significant voxels after family-wise error correction. Considering the statistical power depends on the number of observations, the number of subjects should be increased for providing a statistically con-
